advertisement

WGA Rescources

JAMA ophthalmology 64

Showing records 1 to 25 | Display all abstracts in JAMA ophthalmology

98922 Association of Initial Optical Coherence Tomography Angiography Vessel Density Loss With Faster Visual Field Loss in Glaucoma
Nishida T
JAMA ophthalmology 2022; 140: 319-326
98645 Serious Adverse Events of Oral and Topical Carbonic Anhydrase Inhibitors
Popovic MM
JAMA ophthalmology 2022; 140: 235-242
98787 Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 Years
Repka MX
JAMA ophthalmology 2022; 140: 269-276
99124 Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning
Fan R
JAMA ophthalmology 2022; 140: 383-391
99013 Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program
Delavar A
JAMA ophthalmology 2022; 140: 354-361
98515 Challenges in Elucidating Ophthalmology's Standards of Care: A Review
Hellem A
JAMA ophthalmology 2022; 140: 191-196
99317 Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era
Bellsmith KN
JAMA ophthalmology 2022; 140: 465-471
98380 Perceptions of Respect From Clinicians by Patients in Racial and Ethnic Minority Groups With Eye Disease
Hicks PM
JAMA ophthalmology 2022; 140: 125-131
98515 Challenges in Elucidating Ophthalmology's Standards of Care: A Review
Vanderbeek BL
JAMA ophthalmology 2022; 140: 191-196
99124 Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning
Bowd C
JAMA ophthalmology 2022; 140: 383-391
98787 Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 Years
Dean TW
JAMA ophthalmology 2022; 140: 269-276
98922 Association of Initial Optical Coherence Tomography Angiography Vessel Density Loss With Faster Visual Field Loss in Glaucoma
Moghimi S
JAMA ophthalmology 2022; 140: 319-326
99013 Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program
Radha Saseendrakumar B
JAMA ophthalmology 2022; 140: 354-361
98645 Serious Adverse Events of Oral and Topical Carbonic Anhydrase Inhibitors
Schlenker MB
JAMA ophthalmology 2022; 140: 235-242
99317 Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era
Gale MJ
JAMA ophthalmology 2022; 140: 465-471
98380 Perceptions of Respect From Clinicians by Patients in Racial and Ethnic Minority Groups With Eye Disease
Elam AR
JAMA ophthalmology 2022; 140: 125-131
98787 Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 Years
Kraker RT
JAMA ophthalmology 2022; 140: 269-276
99013 Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program
Weinreb RN
JAMA ophthalmology 2022; 140: 354-361
99124 Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning
Christopher M
JAMA ophthalmology 2022; 140: 383-391
99317 Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era
Yang S
JAMA ophthalmology 2022; 140: 465-471
98380 Perceptions of Respect From Clinicians by Patients in Racial and Ethnic Minority Groups With Eye Disease
Woodward MA
JAMA ophthalmology 2022; 140: 125-131
98645 Serious Adverse Events of Oral and Topical Carbonic Anhydrase Inhibitors
Thiruchelvam D
JAMA ophthalmology 2022; 140: 235-242
98922 Association of Initial Optical Coherence Tomography Angiography Vessel Density Loss With Faster Visual Field Loss in Glaucoma
Wu JH
JAMA ophthalmology 2022; 140: 319-326
99317 Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era
Nguyen IB
JAMA ophthalmology 2022; 140: 465-471
99013 Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program
Baxter SL
JAMA ophthalmology 2022; 140: 354-361

Issue 22-4

Change Issue


advertisement

Oculus